Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
PHASE3
Primary biliary cholangitis (PBC) is a rare chronic, progressive, cholestat...
The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
N/A
This study evaluates the different response of Ursodeoxycholic Acid in prim...
Status
Completed
Location
West China Hospital
Start Date
2016-01-01
Trial ID
NCT03322943
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
PHASE2
Duodenal carcinomas are the leading cause of mortality in patients with Fam...
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
PHASE4
Biochemical response of primary biliary cholangitis-autoimmune hepatitis ov...